A Peptide-Based Assay Discriminates Individual Antibody Response to the COVID-19 Pfizer/BioNTech mRNA Vaccine

The coronavirus disease 2019 (COVID-19) mRNA vaccine developed by Pfizer/BioNTech has been shown to be capable of developing an excellent antibody response against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein, with good production of neutralizing antibodies. Herein,...

Descripción completa

Detalles Bibliográficos
Autores principales: Polvere, Immacolata, Voccola, Serena, Parrella, Alfredina, Cardinale, Gaetano, Zerillo, Lucrezia, Varricchio, Romualdo, Madera, Jessica Raffaella, Stilo, Romania, Vito, Pasquale, Zotti, Tiziana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8471059/
https://www.ncbi.nlm.nih.gov/pubmed/34579224
http://dx.doi.org/10.3390/vaccines9090987

Ejemplares similares

Ejemplares similares